全文获取类型
收费全文 | 253093篇 |
免费 | 17557篇 |
国内免费 | 1047篇 |
专业分类
耳鼻咽喉 | 3220篇 |
儿科学 | 6548篇 |
妇产科学 | 4415篇 |
基础医学 | 32442篇 |
口腔科学 | 5173篇 |
临床医学 | 25188篇 |
内科学 | 52578篇 |
皮肤病学 | 3600篇 |
神经病学 | 23338篇 |
特种医学 | 9389篇 |
外国民族医学 | 4篇 |
外科学 | 38748篇 |
综合类 | 3744篇 |
现状与发展 | 2篇 |
一般理论 | 332篇 |
预防医学 | 22981篇 |
眼科学 | 5705篇 |
药学 | 17830篇 |
4篇 | |
中国医学 | 346篇 |
肿瘤学 | 16110篇 |
出版年
2023年 | 1139篇 |
2022年 | 1823篇 |
2021年 | 4530篇 |
2020年 | 2610篇 |
2019年 | 4296篇 |
2018年 | 5104篇 |
2017年 | 3785篇 |
2016年 | 4087篇 |
2015年 | 4967篇 |
2014年 | 7272篇 |
2013年 | 11112篇 |
2012年 | 16169篇 |
2011年 | 17210篇 |
2010年 | 9687篇 |
2009年 | 9077篇 |
2008年 | 15882篇 |
2007年 | 17022篇 |
2006年 | 16430篇 |
2005年 | 16821篇 |
2004年 | 16042篇 |
2003年 | 15402篇 |
2002年 | 14773篇 |
2001年 | 2404篇 |
2000年 | 1947篇 |
1999年 | 2554篇 |
1998年 | 3230篇 |
1997年 | 2649篇 |
1996年 | 2341篇 |
1995年 | 2305篇 |
1994年 | 1921篇 |
1993年 | 1922篇 |
1992年 | 1549篇 |
1991年 | 1518篇 |
1990年 | 1395篇 |
1989年 | 1322篇 |
1988年 | 1302篇 |
1987年 | 1255篇 |
1986年 | 1271篇 |
1985年 | 1467篇 |
1984年 | 1698篇 |
1983年 | 1648篇 |
1982年 | 2215篇 |
1981年 | 2141篇 |
1980年 | 1852篇 |
1979年 | 1069篇 |
1978年 | 1211篇 |
1977年 | 1118篇 |
1976年 | 945篇 |
1975年 | 860篇 |
1974年 | 816篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context. 相似文献
3.
4.
5.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
6.
7.
8.
Christopher Teng JiaDe Yu Jesse Taylor Adam I. Rubin James R. Treat 《Pediatric dermatology》2019,36(5):697-701
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed. 相似文献
9.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献10.